Article Text

other Versions

MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
  1. Megan M Garrity-Park (garrity.megan{at}
  1. Mayo Clinic, United States
    1. Edward V Loftus, Jr
    1. Mayo Clinic, United States
      1. Sandborn J William
      1. Mayo Clinic, United States
        1. Sandra Bryant
        1. Mayo Clinic, United States
          1. Thomas C Smyrk
          1. Mayo Clinic, United States


            Objectives: Ulcerative colitis (UC) patients are at risk for colorectal cancer (CRC). Although prior studies have shown a link between HLA genotypes and UC susceptibility, none have investigated HLA genotypes and UC-CRC. We therefore investigated HLA-DR/DQ alleles in UC-CRC cases and UC-controls. Furthermore, since methylation of the Class II transactivator (CIITA) gene may silence HLA expression in tumors, we correlated HLA allele frequencies with CIITA gene methylation and HLA-DR expression.

            Methods: Cases and controls were matched for duration/extent of UC, age, ethnicity and gender, but not for primary sclerosing cholangitis (PSC). DNA was extracted from archived tissue blocks from 114 UC-CRC cases and 114 UC-controls. HLA-DR/DQ genotyping was performed using sequence-specific-oligonucleotide polymerase chain reaction (SSO-PCR). CIITA methylation was determined using methylation-specific PCR. HLA-DR immunohistochemistry was done following standard protocols.

            Results: UC-CRC cases were more likely than UC-controls to carry the DR17 or DR13 alleles (p<0.0001 or p=0.02, respectively). Although CIITA methylation did not vary significantly between cases and controls, DR17 and DQ2 were associated with CIITA methylation (p=0.04 and 0.02, respectively). UC-controls more frequently carried the DR7, DR1 or DQ5 alleles (p=0.002, 0.05 or 0.01, respectively). After adjusting for PSC, DR17 remained significantly associated with an increased risk for UC-CRC while DR7 and DQ5 remained protective.

            Conclusions: We report a significant association between specific HLA alleles and either risk for (DR17) or protection from (DR7, DQ5) UC-CRC. This suggests a possible genetic predisposition for increased UC-CRC risk. In addition, DQ2 and DR17 were associated with CIITA methylation.

            Statistics from

            Request permissions

            If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

            Linked Articles